Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
afatinib
1200.23
NCT00656136
Carcinoma, Non-Small-Cell Lung
Phase 3
 
July 2014

Powered by ideaPoint, Inc.